Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.550
+0.010 (0.39%)
At close: Aug 14, 2026, 4:00 PM EDT
2.520
-0.030 (-1.18%)
After-hours: Aug 14, 2026, 7:50 PM EDT
CNTB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 27.02 | 38.35 | 78.23 | 105.66 | 79.01 | 267.72 |
Short-Term Investments | 4.47 | 6 | 15.48 | 12.64 | 73.46 | - |
Cash & Short-Term Investments | 31.49 | 44.34 | 93.71 | 118.3 | 152.47 | 267.72 |
Cash Growth | -56.13% | -52.68% | -20.79% | -22.41% | -43.05% | 70.18% |
Accounts Receivable | 2.94 | 0.01 | 0.79 | - | - | - |
Other Receivables | 0.02 | 0.15 | 0.26 | 0.35 | - | 7.41 |
Receivables | 2.96 | 0.16 | 1.05 | 0.35 | - | 7.41 |
Prepaid Expenses | 4.18 | 6.43 | 2.2 | 3.85 | 3.31 | - |
Other Current Assets | - | - | - | 0.05 | - | - |
Total Current Assets | 38.62 | 50.93 | 96.96 | 122.55 | 155.78 | 275.13 |
Property, Plant & Equipment | 4.16 | 4.46 | 4.24 | 4.74 | 8.47 | 12.89 |
Long-Term Investments | - | - | - | - | 9.44 | - |
Other Intangible Assets | 0.04 | 0.05 | 0.05 | 0.06 | 0.07 | 0.09 |
Other Long-Term Assets | 0.65 | 0.65 | 0.03 | 0.02 | 0.25 | 2.95 |
Total Assets | 43.47 | 56.08 | 101.28 | 127.38 | 174.01 | 291.05 |
Accounts Payable | 2.02 | 1.96 | 0.34 | 2.21 | 11.94 | 12.74 |
Accrued Expenses | 13.89 | 11.16 | 7.8 | 9.48 | 2.96 | - |
Current Portion of Leases | 0.39 | 0.32 | 0.15 | 0.29 | 0.19 | 0.1 |
Current Unearned Revenue | - | 0.17 | 0.16 | 13.32 | - | - |
Other Current Liabilities | - | - | - | - | 0.54 | 5.15 |
Total Current Liabilities | 16.3 | 13.61 | 8.46 | 25.29 | 15.62 | 17.99 |
Long-Term Leases | 0.2 | 0.37 | 0.02 | 0.18 | 0.25 | 0.03 |
Long-Term Unearned Revenue | - | - | - | - | 0.65 | 0.78 |
Other Long-Term Liabilities | 0.11 | 0.11 | 0.63 | 0.41 | - | - |
Total Liabilities | 16.61 | 14.1 | 9.12 | 25.88 | 16.52 | 18.8 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 465.51 | 444.18 | 439.36 | 432.4 | 628.66 | 628.64 |
Retained Earnings | -437.52 | -400.84 | -345.36 | -329.73 | -479.84 | -361.75 |
Treasury Stock | -0.18 | -0.18 | -0.18 | -0.18 | -0.18 | -0.18 |
Comprehensive Income & Other | -0.96 | -1.19 | -1.67 | -1.01 | 8.85 | 5.54 |
Shareholders' Equity | 26.86 | 41.98 | 92.17 | 101.5 | 157.49 | 272.26 |
Total Liabilities & Equity | 43.47 | 56.08 | 101.28 | 127.38 | 174.01 | 291.05 |
Total Debt | 0.6 | 0.69 | 0.18 | 0.47 | 0.43 | 0.13 |
Net Cash (Debt) | 30.89 | 43.65 | 93.53 | 117.84 | 152.04 | 267.59 |
Net Cash Growth | -56.43% | -53.33% | -20.63% | -22.49% | -43.18% | - |
Net Cash Per Share | 0.53 | 0.78 | 1.69 | 2.14 | 2.76 | 5.13 |
Filing Date Shares Outstanding | 62.97 | 56.52 | 55.35 | 55.1 | 55.04 | 55.08 |
Total Common Shares Outstanding | 62.97 | 56.44 | 55.35 | 55.1 | 55.04 | 55.08 |
Working Capital | 22.32 | 37.32 | 88.5 | 97.26 | 140.16 | 257.14 |
Book Value Per Share | 0.43 | 0.74 | 1.67 | 1.84 | 2.86 | 4.94 |
Tangible Book Value | 26.82 | 41.94 | 92.11 | 101.44 | 157.42 | 272.17 |
Tangible Book Value Per Share | 0.43 | 0.74 | 1.66 | 1.84 | 2.86 | 4.94 |
Machinery | - | 6.24 | 5.85 | 5.68 | 5.84 | 5.77 |
Construction In Progress | - | - | - | - | - | 3.7 |
Leasehold Improvements | - | 0.86 | 0.83 | 0.63 | 0.76 | 0.73 |